Position in DFTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$570,780
New position
Shares Held
30,200
first reported quarter
Ownership
0.028%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Rathbones Group PLC holds $8,220,550 across 18 Biotechnology names. DFTX ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PTCT |
Ptc Therapeutics, Inc.
|
23,500 | $1,601,055 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
23,666 | $1,376,177 | |
| 3 | IBRX |
ImmunityBio, Inc.
|
153,420 | $1,176,731 | |
| 4 | ORMP |
Oramed Pharmaceuticals Inc.
|
233,018 | $792,261 | |
| 5 | MRNA |
Moderna, Inc.
|
13,778 | $699,922 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
This page
|
30,200 | $570,780 | |
| 7 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
955 | $426,445 | |
| 8 | VIR |
Vir Biotechnology, Inc.
|
28,611 | $256,354 |
All Filings in DFTX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $570,780 | 30,200 | Shares | Sole | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||